Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes

Details for Australian Patent Application No. 2002342317 (hide)

International Classifications

Event Publications

27 February 2003 Complete Application Filed

Priority application(s): 01111651.4 14.05.01 EP

1 May 2003 Application Open to Public Inspection

Published as AU-A-2002342317

5 January 2006 Change of Name(s) of Applicant(s), Section 104

Aventis Pharma Deutschland GmbH The name of the applicant has been changed to Sanofi-Aventis Deutschland GmbH 2003

3 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.